Advanced Filters
noise

A, Kuopio N Clinical Trials

A listing of A, Kuopio N clinical trials actively recruiting patients volunteers.

Found 11,120 clinical trials
V Victor Tellez

A Trial of Selinexor, Ruxolitinib and Methylprednisolone

Selinexor, a first-in-class, oral selective exportin 1 (XPO1) inhibitor, has shown promise in pre-clinical and clinical studies. It functions by inhibiting the nuclear export protein XPO1, resulting in the accumulation of tumor suppressor proteins and inhibition of oncoprotein mRNAs, which is selectively lethal to myeloma cells. Selinexor has demonstrated activity …

years of age All Phase 1

A Study of LY3867070 in Healthy Participants

The purpose of this study is to evaluate how well LY3867070 is tolerated and what side effects may occur in healthy participants. The study drug will be administered orally. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the …

18 - 65 years of age All Phase 1
J Jan Tack, PhD, MD

Budesonide as a Treatment for Functional Dyspepsia

This clinical study is being conducted to evaluate the investigational drug, Budesonide, for the treatment of functional dyspepsia. The goal of this study is to learn more about the effect of Budesonide on patients with functional dyspepsia. Budesonide is a well-known and commonly used drug, and is part of the …

18 - 70 years of age All Phase 4
S Seth Price

A Study of IBI3032 in Healthy Participants

This is a randomized, double-blind, placebo-controlled Phase I clinical study evaluating the safety, tolerability, and PK of a single dose of IBI3032 in healthy participants. This is a single ascending dose (SAD) study. Approximately 32 healthy participants are expected to be enrolled in this study. The screening period is 4 …

18 - 65 years of age All Phase 1

A Study of LY3981314 in Healthy Participants

The main purpose of this study is to investigate the safety of LY3981314 when administered subcutaneously (SC) (under the skin), and how it's processed in the body. The study will last approximately 25 weeks, excluding a screening period with an optional extension to approximately 49 weeks for qualifying participants.

18 - 65 years of age All Phase 1
M Mariella Cataldo

A Multi-domain Intervention for Healthy Aging

This study aims to investigate the long-term impact of a non-pharmacological intervention including several activities (e.g., physical activity, choir, learning programs, horticulture, etc.) to prevent cognitive impairment in community-dwelling elderly individuals with aspects of frailty. The main questions it aims to answer are: Does engaging in multiple activities, including music, …

65 years of age All Phase N/A

A Study of LY4088044 in Healthy Participants

The purpose of this study is to evaluate how well LY4088044 is tolerated and what side effects may occur in healthy participants. The study drug will be administered either subcutaneously (SC) (under the skin) or intravenously (IV) (into a vein in the arm). Blood tests will be performed to check …

18 - 65 years of age All Phase 1
N Nucleus Network Brisbane

A Study of CPTX2309 in Healthy Participants

The purpose of this study is to assess the safety and tolerability of CPTX2309 in healthy adult participants.

18 - 55 years of age All Phase 1
J Jane Kelly

A Phase 1 Study of S-1117

This is the first-in-human study of S-1117 designed to provide safety, tolerability, pharmacokinetic, and pharmacodynamic data in healthy volunteers.

18 - 65 years of age All Phase 1
L Leighann Martinez

Testing a Non-Invasive Spinal Stimulation Device

The purpose of this study is to compare an updated spinal stimulation device with the spinal stimulation device that is currently used. Spinal stimulation is often used in studies aimed at assisting individuals with a spinal cord injury. This device was updated to improve upon limitations in the currently used …

18 years of age All Phase N/A

Simplify language using AI